The largest study ever to look at why an expensive and commonly used group of drugs fails patients with Crohn’s disease has concluded that standardised drug doses are often too low. A UK wide collaboration led by the University of Exeter and the Royal Devon & Exeter NHS Foundation Trust, part-funded by Crohn’s & Colitis...